Estimating population attributable fractions to quantify the health burden of obesity

Annals of Epidemiology

Volumn 25, Issue 3, 2015, Pages 201-207

  Flegal, Katherine M ^a   Panagiotou, Orestis A ^b   Graubard, Barry I ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Body mass index; Body weight; Epidemiologic methods; Obesity; Risk

Indexed keywords

ARTICLE; CALCULATION; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HUMAN; INCIDENCE; MEDLINE; MORTALITY; NEOPLASM; OBESITY; OUTCOME ASSESSMENT; POPULATION; POPULATION ATTRIBUTABLE FRACTION; PRIORITY JOURNAL; RISK FACTOR; BODY MASS; BODY WEIGHT; COST OF ILLNESS; EPIDEMIOLOGY; HEALTH SURVEY; MALE; PREVALENCE; PSYCHOLOGY; RISK; UNITED STATES;

BODY MASS INDEX; BODY WEIGHT; COST OF ILLNESS; EPIDEMIOLOGIC METHODS; HUMANS; INCIDENCE; MALE; OBESITY; POPULATION SURVEILLANCE; PREVALENCE; RISK; RISK FACTORS; UNITED STATES;

EID: 84923277725     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2014.11.010     Document Type: Article

References (90)

1. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311(8):806-814.
2. Guh D.P., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A.H. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009, 9:88.
3. Levin M.L. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953, 9(3):531-541.
4. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998, 158(17):1855-1867.
5. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894:i-xii. 1-253.
6. Flegal K.M., Shepherd J.A., Looker A.C., Graubard B.I., Borrud L.G., Ogden C.L., et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr 2009, 89(2):500-508.
7. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995, 854:1-452.
8. Adams K.F., Schatzkin A., Harris T.B., Kipnis V., Mouw T., Ballard-Barbash R., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. NEngl J Med 2006, 355(8):763-778.
9. James W.P.T., Jackson-Leach R., Ni Mhurchu C., Kalamara E., Shayeghi M., Rigby N.J., et al. Overweight and obesity (high body mass index). Comparative quantification of health risks 2004, 497-596. World Health Organization, Geneva. M. Ezzati, A.D. Lopez, C.J.L. Rodgers A,.Murray (Eds.).
10. Rockhill B., Newman B., Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998, 88(1):15-19.
11. Wilson P.W., D'Agostino R.B., Sullivan L., Parise H., Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002, 162(16):1867-1872.
12. Katzmarzyk P.T., Craig C.L., Bouchard C. Original article underweight, overweight and obesity: relationships with mortality in the 13-year follow-up of the Canada Fitness Survey. JClin Epidemiol 2001, 54(9):916-920.
13. Katzmarzyk P.T., Ardern C.I. Overweight and obesity mortality trends in Canada, 1985-2000. Can J Public Health 2004, 95(1):16-20.
14. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. NEngl J Med 2003, 348(17):1625-1638.
15. Boffetta P., McLaughlin J.K., La Vecchia C., Autier P., Boyle P. 'Environment' in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis 2007, 28(5):913-915.
16. Chiolero A., Peytremann-Bridevaux I., Paccaud F. Associations between obesity and health conditions may be overestimated if self-reported body mass index is used. Obes Rev 2007, 8(4):373-374.
17. Faeh D., Roh L., Paccaud F., Chiolero A. Mortality risk of obesity and underweight is overestimated with self-reported body mass index. Epidemiology 2014, 25(1):156-158.
18. Danaei G., Ding E.L., Mozaffarian D., Taylor B., Rehm J., Murray C.J., et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009, 6(4):e1000058.
19. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363(9403):157-163.
20. Smith L., Brinton L.A., Spitz M.R., Lam T.K., Park Y., Hollenbeck A.R., et al. Body mass index and risk of lung cancer among never, former, and current smokers. JNatlcancer Inst 2012, 104(10):778-789.
21. Hernan M.A., Taubman S.L. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes(Lond) 2008, 32(Suppl 3):S8-14.
22. Vandenbroucke J.P., von Elm E., Altman D.G., Gotzsche P.C., Mulrow C.D., Pocock S.J., et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 2007, 18(6):805-835.
23. Benichou J. Areview of adjusted estimators of attributable risk. Stat Methods Med Res 2001, 10(3):195-216.
24. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Sources of differences in estimates of obesity-associated deaths from first National Health and Nutrition Examination Survey (NHANES I) hazard ratios. Am J Clin Nutr 2010, 91(3):519-527.
25. Spiegelman D., Hertzmark E., Wand H.C. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control 2007, 18(5):571-579.
26. Bruzzi P., Green S.B., Byar D.P., Brinton L.A., Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985, 122(5):904-914.
27. van Dis I., Kromhout D., Geleijnse J.M., Boer J.M., Verschuren W.M. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years. Eur J Cardiovasc Prev Rehabil 2009, 16(6):729-734.
28. Forman J.P., Stampfer M.J., Curhan G.C. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 2009, 302(4):401-411.
29. Allison D.B., Fontaine K.R., Manson J.E., Stevens J., VanItallie T.B. Annual deaths attributable to obesity in the United States. JAMA 1999, 282(16):1530-1538.
30. Mokdad A.H., Marks J.S., Stroup D.F., Gerberding J.L. Actual causes of death in the United States, 2000. JAMA 2004, 291(10):1238-1245.
31. Preston S.H., Stokes A. Contribution of obesity to international differences in life expectancy. Am J Public Health 2011, 101(11):2137-2143.
32. Vander Hoorn S., Ezzati M., Rodgers A., Lopez A.D., Murray C.J.L. Chapter 25. Estimating attributable burden of disease from exposure and hazard data. Comparative quantification of health risks 2004, World Health Organization, Geneva. M. Ezzati, A.D. Lopez, A. Rodgers, C.J.L. Murray (Eds.).
33. Steenland K., Armstrong B. An overview of methods for calculating the burden of disease due to specific risk factors. Epidemiology 2006, 17(5):512-519.
34. Uter W., Pfahlberg A. The application of methods to quantify attributable risk in medical practice. Stat Methods Med Res 2001, 10(3):231-237.
35. Allender S., Rayner M. The burden of overweight and obesity-related ill health in the UK. Obes Rev 2007, 8(5):467-473.
36. Banegas J.R., Lopez-Garcia E., Gutierrez-Fisac J.L., Guallar-Castillon P., Rodriguez-Artalejo F. Asimple estimate of mortality attributable to excess weight in the European Union. Eur J Clin Nutr 2003, 57(2):201-208.
37. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005, 293(15):1861-1867.
38. Iversen L., Hannaford P.C., Lee A.J., Elliott A.M., Fielding S. Impact of lifestyle in middle-aged women on mortality: evidence from the Royal College of General Practitioners' Oral Contraception Study. Br J Gen Pract 2010, 60(577):563-569.
39. Kelly C., Pashayan N., Munisamy S., Powles J.W. Mortality attributable to excess adiposity in England and Wales in 2003 and 2015: explorations with a spreadsheet implementation of the Comparative Risk Assessment methodology. Popul Health Metr 2009, 7:11.
40. Mehta N.K., Chang V.W. Mortality attributable to obesity among middle-aged adults in the United States. Demography 2009, 46(4):851-872.
41. Muennig P., Lubetkin E., Jia H., Franks P. Gender and the burden of disease attributable to obesity. Am J Public Health 2006, 96(9):1662-1668.
42. Ringback Weitoft G., Eliasson M., Rosen M. Underweight, overweight and obesity as risk factors for mortality and hospitalization. Scand J Public Health 2008, 36(2):169-176.
43. van Dam R.M., Li T., Spiegelman D., Franco O.H., Hu F.B. Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ 2008, 337:a1440.
44. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Weight-associated deaths in the United States. JWomens Health (Larchmt) 2007, 16(9):1368-1370.
45. Bergstrom A., Pisani P., Tenet V., Wolk A., Adami H.O. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001, 91(3):421-430.
46. Boffetta P., Tubiana M., Hill C., Boniol M., Aurengo A., Masse R., et al. The causes of cancer in France. Ann Oncol 2008.
47. Boswell-Purdy J., Flanagan W.M., Roberge H., Le Petit C., White K.J., Berthelot J.M. Population health impact of cancer in Canada, 2001. Chronic Dis Can 2007, 28(1-2):42-55.
48. Danaei G., Vander Hoorn S., Lopez A.D., Murray C.J., Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005, 366(9499):1784-1793.
49. Dreyer L., Winther J.F., Olsen J. Avoidable deaths from cancer in the Nordic countries around the year 2000. Scand J Public Health 2001, 29(4):318-319.
50. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298(17):2028-2037.
51. Inoue M., Sawada N., Matsuda T., Iwasaki M., Sasazuki S., Shimazu T., et al. Attributable causes of cancer in Japan in 2005-systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan. Ann Oncol 2012, 23(5):1362-1369.
52. Kuriyama S. Impact of overweight and obesity on medical care costs, all-cause mortality, and the risk of cancer in Japan. JEpidemiol 2006, 16(4):139-144.
53. Lukanova A., Bjor O., Kaaks R., Lenner P., Lindahl B., Hallmans G., et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006, 118(2):458-466.
54. Ott J.J., Ullrich A., Mascarenhas M., Stevens G.A. Global cancer incidence and mortality caused by behavior and infection. JPublic Health (Oxf) 2011, 33(2):223-233.
55. Pan S.Y., Johnson K.C., Ugnat A.M., Wen S.W., Mao Y. Association of obesity and cancer risk in Canada. Am J Epidemiol 2004, 159(3):259-268.
56. Parkin D.M., Boyd L. 8. Cancers attributable to overweight and obesity in the UK in 2010. Br J Cancer 2011, 105(Suppl 2):S34-S37.
57. Polednak A.P. Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev 2008, 32(3):190-199.
58. Reeves G.K., Pirie K., Beral V., Green J., Spencer E., Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007, 335(7630):1134.
59. Renehan A.G., Soerjomataram I., Tyson M., Egger M., Zwahlen M., Coebergh J.W., et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 2010, 126(3):692-702.
60. Wang D., Zheng W., Wang S.M., Wang J.B., Wei W.Q., Liang H., et al. Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr Cancer 2012, 64(1):48-56.
61. National Cancer Institute. Obesity and cancer risk 2012. Available from:. Accessed June 3, 2014. http://www.cancer.gov/cancertopics/factsheet/Risk/obesity.
62. Wilson L.F., Page A.N., Dunn N.A., Pandeya N., Protani M.M., Taylor R.J. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia. Maturitas 2013, 76(4):370-376.
63. Arnold L.D., Patel A.V., Yan Y., Jacobs E.J., Thun M.J., Calle E.E., et al. Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?. Cancer Epidemiol Biomarkers Prev 2009, 18(9):2397-2405.
64. Trichopoulos D., Bamia C., Lagiou P., Fedirko V., Trepo E., Jenab M., et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. JNatl Cancer Inst 2011, 103(22):1686-1695.
65. Chang Y., Schechter C.B., van Ravesteyn N.T., Near A.M., Heijnsdijk E.A., Adams-Campbell L., et al. Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality. Breast Cancer Res Treat 2012, 136(3):823-835.
66. Smith M., Zhou M., Whitlock G., Yang G., Offer A., Hui G., et al. Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 2008, 122(7):1604-1610.
67. de Hollander E.L., VanZutphen M., Bogers R.P., Bemelmans W.J., de Groot L.C. The impact of body mass index in old age on cause-specific mortality. JNutr Health Aging 2012, 16(1):100-106.
68. Dunlay S.M., Weston S.A., Jacobsen S.J., Roger V.L. Risk factors for heart failure: a population-based case-control study. Am J Med 2009, 122(11):1023-1028.
69. Faeh D., Braun J., Tarnutzer S., Bopp M. Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country. Eur J Prev Cardiol 2013, 20(1):151-160.
70. Flint A.J., Hu F.B., Glynn R.J., Caspard H., Manson J.E., Willett W.C., et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) 2009.
71. Huxley R.R., Lopez F.L., Folsom A.R., Agarwal S.K., Loehr L.R., Soliman E.Z., et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011, 123(14):1501-1508.
72. Loehr L.R., Rosamond W.D., Poole C., McNeill A.M., Chang P.P., Deswal A., et al. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol 2010, 172(7):781-789.
73. Mann D.M., Lee J., Liao Y., Natarajan S. Independent effect and population impact of obesity on fatal coronary heart disease in adults. Prev Med 2006, 42(1):66-72.
74. Schnohr P., Jensen J.S., Scharling H., Nordestgaard B.G. Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study. Eur Heart J 2002, 23(8):620-626.
75. Seidell J.C., Verschuren W.M., van Leer E.M., Kromhout D. Overweight, underweight, and mortality. A prospective study of 48,287 men and women. Arch Intern Med 1996, 156(9):958-963.
76. Atlantis E., Lange K., Wittert G.A. Chronic disease trends due to excess body weight in Australia. Obes Rev 2009, 10(5):543-553.
77. Chan J.M., Rimm E.B., Colditz G.A., Stampfer M.J., Willett W.C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994, 17(9):961-969.
78. Dal Grande E., Gill T., Wyatt L., Chittleborough C.R., Phillips P.J., Taylor A.W. Population attributable risk (PAR) of overweight and obesity on chronic diseases: South Australian representative, cross-sectional data, 2004-2006. Obes Res Clin Pract 2009, 3(3):I-IV.
79. Hart C.L., Hole D.J., Lawlor D.A., Davey Smith G. How many cases of Type 2 diabetes mellitus are due to being overweight in middle age? Evidence from the Midspan prospective cohort studies using mention of diabetes mellitus on hospital discharge or death records. Diabet Med 2007, 24(1):73-80.
80. Hosseinpanah F., Rambod M., Azizi F. Population attributable risk for diabetes associated with excess weight in Tehranian adults: a population-based cohort study. BMC Public Health 2007, 7:328.
81. Hu F.B., Manson J.E., Stampfer M.J., Colditz G., Liu S., Solomon C.G., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. NEngl J Med 2001, 345(11):790-797.
82. Jiang Y., Chen Y., Mao Y. The contribution of excess weight to prevalent diabetes in Canadian adults. Public Health 2008, 122(3):271-276.
83. Laaksonen M.A., Knekt P., Rissanen H., Harkanen T., Virtala E., Marniemi J., et al. The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts. Eur J Epidemiol 2010, 25(2):115-124.
84. Martiniuk A.L., Lee C.M., Colagiuri S., Woodward M. Higher-than-optimal body mass index and diabetes mortality in the Asia Pacific region. Diabetes Res Clin Pract 2011, 94(3):471-476.
85. Darrow L.A., Steenland N.K. Confounding and bias in the attributable fraction. Epidemiology 2011, 22(1):53-58.
86. Greenland S. Bias in methods for deriving standardized morbidity ratio and attributable fraction estimates. Stat Med 1984, 3(2):131-141.
87. Greenland S., Robins J.M. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 1988, 128(6):1185-1197.
88. Walter S.D. Effects of interaction, confounding and observational error on attributable risk estimation. Am J Epidemiol 1983, 117(5):598-604.
89. Whittemore A.S. Estimating attributable risk from case-control studies. Am J Epidemiol 1983, 117(1):76-85.
90. Williamson D.F. The population attributable fraction and confounding: buyer beware. Int J Clin Pract 2010, 64(8):1019-1023.